Association between fentanyl use and virologic suppression in an HIV-infected cohort of people who use/inject drugs (PWID): results from a bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) switch study

被引：0
|
作者：
Conway, B. [1 ,2 ]
Yi, S. [1 ]
Sharma, S. [1 ]
Yung, R. [1 ]
Truong, D. [1 ]
机构：
[1] Vancouver Infect Dis Ctr, Vancouver, BC, Canada
[2] Simon Fraser Univ, Burnaby, BC, Canada
来源：
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY | 2022年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P127
引用
收藏
页码：121 / 122
页数：2
相关论文
共 43 条
  • [1] Intermittent bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) maintains viral suppression in real life in controlled HIV-infected patients
    Sellem, B.
    Abdi, B.
    Peytavin, G.
    Tubiana, R.
    Valantin, M. -A.
    Seang, S.
    Schneider, L.
    Faycal, A.
    Soulie, C.
    Marcelin, A. -G.
    Katlama, C.
    Pourcher, V.
    Palich, R.
    HIV MEDICINE, 2021, 22 : 90 - 91
  • [2] Switch to bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) among vulnerable HIV-infected individuals: evidence for long-term efficacy
    Truong, David
    Yi, Shana
    Wiesmann, Christina
    Conway, Brian
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2024, 27 : 181 - 181
  • [3] Restarting bictegravir/ emtricitabine/tenofovir alafenamide (B/F/TAF) after virologic rebound: A pooled analysis of studies in people with HIV-1
    Pozniak, A.
    Orkin, C.
    Maggiolo, F.
    Yazdanpanah, Y.
    Baumgarten, A.
    Mounzer, K.
    D'Antoni, M. L.
    Huang, H.
    Liu, H.
    Andreatta, K.
    VanderVeen, L.
    Callebaut, C.
    Hindman, J. T.
    Martin, H.
    Arribas, J. R.
    HIV MEDICINE, 2023, 24 : 195 - 196
  • [4] Use of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in kidney transplant recipients living with HIV-1 receiving calcineurin and mTOR inhibitors: a pilot switch study
    Gallien, Sebastien
    Assoumou, Lambert
    Dantal, Jacques
    Hulin, Anne
    Benalycherif, Aida
    Ben Rayana, Raida
    Tobbal, Yasmine
    Matignon, Marie
    Melica, Giovanna
    Allavena, Clotilde
    Stehle, Thomas
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2024, 27 : 286 - 287
  • [5] Bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) shows high efficacy in clinical study participants infected with HIV-1 subtype F
    Acosta, R.
    Andreatta, K.
    D'Antoni, M.
    Collins, S.
    Martin, H.
    White, K.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2020, 23 : 106 - 106
  • [6] Switch to bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in people living with HIV aged 65 years or older: W24 results of the BICOLDER study - IMEA 057
    Allavena, C.
    Joly, V.
    Assoumou, L.
    Isernia, V.
    Ajana, F.
    Neau, D.
    Descamps, D.
    Charpentier, C.
    Benalycherif, A.
    Metivier, E.
    Peytavin, G.
    Phung, B.
    Landman, R.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2022, 25 : 47 - 47
  • [7] Week 48 outcomes from the BRAAVE 2020 study: a randomised switch to bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in African American adults with HIV
    Hagins, D.
    Kumar, P.
    Wurapa, A.
    Brar, I.
    Berger, D.
    Osiyemi, O.
    Hileman, C.
    Ramgopal, M.
    McDonald, C.
    Blair, C.
    Andreatta, K.
    Collins, S. E.
    Brainard, D.
    Gohlar, G.
    Martin, H.
    HIV MEDICINE, 2021, 22 : 33 - 34
  • [8] Bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in treatment-naïve and treatment-experienced people with HIV: 12-month virologic effectiveness and safety outcomes in the BICSTaR Japan cohort
    Yokomaku, Yoshiyuki
    Teruya, Katsuji
    Watanabe, Dai
    Endo, Tomoyuki
    Minami, Rumi
    Taguchi, Nao
    Cassidy, Tali
    Marongiu, Andrea
    Thorpe, David
    Shirasaka, Takuma
    Oka, Shinichi
    PLOS ONE, 2025, 20 (01):
  • [9] Effectiveness, safety and tolerability of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in HIV-1 infected adult patients in routine clinical practice-6 months results of the BICSTaR cohort
    Esser, S.
    Jessen, H.
    Schneider, J.
    Schellberg, S.
    Stellbrink, H-J
    Waizmann, M.
    Hillenbrand, H.
    Bilbao, P.
    Schreiber, S.
    Thorpe, D.
    Ramroth, H.
    Haubrich, R.
    Heinzkill, M.
    HIV MEDICINE, 2019, 20 : 61 - 61
  • [10] Pharmacokinetics, safety and efficacy study in pregnancy and existing cumulative data/evidence to support clinical use and labelling of bictegravir/ emtricitabine/tenofovir alafenamide (B/F/TAF) in pregnant women with HIV
    Marathe, Dhananjay
    Arora, Priyanka
    Zhang, Haeyoung
    Hindman, Jason
    Liu, Hui
    Girish, Sandhya
    Davis, Casey
    Palaparthy, Ramesh
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 90 : 19 - 19
12345